Arm unveiled its first in-house CPU, shifting business model; Raymond James upgraded to Outperform with $166 PT (~23% upside). This move into fabless chip design is expected to boost operating profit and create a new revenue stream on top of licensing, timed with the AI data center CPU demand boom. The strategic shift is seen as a positive catalyst that may not be fully priced in, offering potential upside. Execution risk in new business line; increased competition with INTC and AMD; potential for market to have already priced in the news.
Arm unveiled its first in-house CPU, shifting business model; Raymond James upgraded to Outperform with $166 PT (~23% upside). This move into fabless chip design is expected to boost operating profit and create a new revenue stream on top of licensing, timed with the AI data center CPU demand boom. The strategic shift is seen as a positive catalyst that may not be fully priced in, offering potential upside. Execution risk in new business line; increased competition with INTC and AMD; potential for market to have already priced in the news.